|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print December 12, 2002
Am J Physiol Heart Circ Physiol, 10.1152/ajpheart.00781.2002
Submitted on September 5, 2002
Accepted on December 4, 2002
, but not
, in En Face Arterial Endothelium
1 Department of Physiology, University of British Columbia, Vancouver, British Columbia, Canada
* To whom correspondence should be addressed. E-mail: edmoore{at}interchange.ubc.ca.
Rapid, non-genomic, effects of 17
-estradiol (E2) in endothelial cells are postulated to arise from membrane-associated estrogen receptors (ER), which have not been visualized in vascular tissue. To identify membrane ERs we used multiple site-directed ER
or ER
antibodies to label en face rat cerebral and coronary arterial endothelia. Western blots revealed a novel 55 kDa ER
isoform. Three-dimensional images of cells labeled with these antibodies, and markers for the nucleus and caveolin-1, were acquired with a wide-field microscope, deconvolved, and numerically analyzed. We found ER
in the nucleus and the cell periphery, where one-third colocalized with caveolin-1. The receptor location was dependent on the antibody's epitope. Human ovarian surface epithelium produced similar results, but in rat myometrium the distribution was epitope-independent and nuclear. ER
distribution was predominately intranuclear and epitope-independent. A small amount of ER
colocalized with ER
within the nucleus. The results were identical in both arterial preparations and insensitive to E2. We postulate that the different ER
conformations at the membrane, in the nucleus and between different cell types allow E2 to trigger cell and location specific signaling cascades.
This article has been cited by other articles:
![]() |
P. Galluzzo, C. Rastelli, P. Bulzomi, F. Acconcia, V. Pallottini, and M. Marino 17{beta}-Estradiol regulates the first steps of skeletal muscle cell differentiation via ER-{alpha}-mediated signals Am J Physiol Cell Physiol, November 1, 2009; 297(5): C1249 - C1262. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. Patel and R. R. Arora Review: Endothelial dysfunction: A potential tool in gender related cardiovascular disease Therapeutic Advances in Cardiovascular Disease, April 1, 2008; 2(2): 89 - 100. [Abstract] [PDF] |
||||
![]() |
D. N. Krause, S. P. Duckles, and D. A. Pelligrino Influence of sex steroid hormones on cerebrovascular function J Appl Physiol, October 1, 2006; 101(4): 1252 - 1261. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Guzzo, M. Salih, E. D. Moore, and B. S. Tuana Molecular properties of cardiac tail-anchored membrane protein SLMAP are consistent with structural role in arrangement of excitation-contraction coupling apparatus Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1810 - H1819. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. X. Liao, R. R. Magness, and D.-b. Chen Expression of Estrogen Receptors-{alpha} and -{beta} in the Pregnant Ovine Uterine Artery Endothelial Cells In Vivo and In Vitro Biol Reprod, March 1, 2005; 72(3): 530 - 537. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Orshal and R. A. Khalil Gender, sex hormones, and vascular tone Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2004; 286(2): R233 - R249. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Watson and B. Gametchu Proteins of Multiple Classes May Participate in Nongenomic Steroid Actions Experimental Biology and Medicine, December 1, 2003; 228(11): 1272 - 1281. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |